|
Apoc incident # (b)(4).Apoc labeling was evaluated during the investigation as pertaining to the event.The investigation was completed on 09/07/2016.Retain product was tested and functioning according to specification.Return product was not available for investigation.Investigation: the customer reported obtaining unexpected na+ and k+ results while using ec8+ cartridge lot k15324 to test a patient sample.The device history record for this lot was reviewed.The lot passed finished goods release criteria.Ec8+ lot k15324 expired (14-jun-16) before retain cartridge testing could be performed.As of 01-sep-16, 18,900 cartridges from lot k15324 have been distributed.No other site has reported observing discrepant na+ or k+ results.No deficiency has been identified.Assessment: the complaint investigation concluded there was no product deficiency and that the i-stat cartridge lot is meeting specification.
|
|
On (b)(6) 2016, abbott point of care was contacted by a customer regarding i-stat ec8+ cartridges that yielded suspected discrepant sodium and potassium results on a patient (dog).The customer stated that the patient passed away at a later date before retesting.The cause of death is unknown.There was no additional patient information available at the time of this report.Return product is not available for investigation.Date: time: method: na+ result meq/l: k+ result meq/l: sample: (b)(6) 2016, 10:16am, i-stat, 118 meq/l, > 9meq/l , a.(b)(6) 2016, 11:15am, vs2, unreadable, 3.7 meq/l, b.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by apoc, however this mdr is a retrospective filing in response to an observation from an fda inspection conducted may 8th to 12th, 2017 at abbott point of care (b)(4).
|